Myoclonic astatic epilepsy: an age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive

Marina Trivisano1, Nicola Specchio, Simona Cappelletti

  • 1Clinic of Nervous System Diseases, University of Foggia, Foggia, Italy.

Epilepsy Research
|August 30, 2011
PubMed

Insights

Myoclonic-astatic epilepsy (MAE) is a childhood epilepsy with a good seizure outcome, though cognitive function may decline. Most children achieve seizure remission within years, with EEG abnormalities resolving over time.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Myoclonic-astatic epilepsy (MAE) is a rare form of generalized childhood epilepsy.
  • Understanding its clinical, electroencephalographic (EEG), and neuropsychological characteristics is crucial for prognosis.

Purpose of the Study:

  • To investigate the clinical features, EEG findings, neuropsychological profile, and long-term prognosis of children diagnosed with myoclonic-astatic epilepsy.

Main Methods:

  • Retrospective analysis of 18 children diagnosed with MAE between 2000 and 2008.
  • Evaluation of clinical seizure types, EEG data, neuropsychological assessments, and follow-up outcomes.

Main Results:

  • MAE predominantly affects males, with onset typically around 3.6 years.
  • Patients presented with various seizure types including absences and generalized tonic-clonic seizures; 38.9% had epileptic encephalopathy.
  • EEG abnormalities resolved within 4 years; 66.7% had normal IQ post-treatment, and 16 out of 18 patients achieved remission.

Conclusions:

  • Myoclonic-astatic epilepsy is a generalized childhood epilepsy with a generally favorable seizure prognosis.
  • While cognitive functions may be affected, most patients achieve remission, and EEG abnormalities are often transient.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...